• OPEN AN ACCOUNT
Indian Indices
Nifty
26,046.95 148.40
(0.57%)
Sensex
85,192.26 -75.40
( -0.09%)
Bank Nifty
59,389.95 180.10
( 0.30%)
Nifty IT
38,274.75 177.75
( 0.47%)
Global Indices
Nasdaq
48,475.79 -249.23
(-0.51%)
Dow Jones
6,848.05 -73.95
(-1.07%)
Hang Seng
50,843.93 695.11
(1.39%)
Nikkei 225
9,668.36 -34.80
(-0.36%)
Forex
USD-INR
90.19 0.30
(0.34%)
EUR-INR
105.70 1.00
(0.96%)
GBP-INR
120.75 0.96
(0.80%)
JPY-INR
0.58 0.01
(0.91%)

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
500660
INE159A01016
100.5174369
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLAXO
46.5
44011.69
EPS(TTM)
Face Value()
Div & Yield %
55.87
10
2.08
 

As on: Dec 15, 2025 12:07 PM

Last Price() Net Change (%) Volume (Nos) P / E
2,576.80 -21.20 54429 46.50
Stock Price Details
Open Price() 2,562.35
Best Buy () 2577.5
Best Sell () 2581.95
Buy Quantity (Nos) 1
Sell Quantity (Nos) 3
Today's High () 2,605.00
Today's Low () 2,562.35
52-Week High () 3515.95
152-Week Low () 1924.3
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 2.08
Eps 55.87
Book Value 100.5174369
Market Cap (.Cr) 44,011.69
Face Value 10
Market Lot 1
AGM Date Jun
Book Closure Date
ISIN No. INE159A01016


News
Indices tumble in early trade; breadth weak
Glaxosmithkline Pharmaceuticals consolidated net profit rises 1.98% in the September 2025 quarter
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Press Release
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Outcome of Board Meeting
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Investor Presentation
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Outcome of Board Meeting
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con. Call Updates
GlaxoSmithKline Pharmaceuticals schedules board meeting
Glaxosmithkline Pharmaceuticals Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Trading Window
More
Corporate Details
Incoporation Year   : 1924
Chairman : Renu S Karnad
Bussiness Group : MNC Asc-Glaxo
Registered Office
Glaxosmithkline Pharmaceuticals Ltd
GSK House,
Dr Annie Besant Road Worli,
Mumbai,
Maharashtra-400030
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-022-24959595
Fax:91-022-24959494
Fax:91-22-66317458
E-Mail : askus@gsk.com; ajay.a.nadkarni@gsk.com
URL : http://www.gsk-india.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE 200
  • BSE HC
  • BSE DOLLEX
  • BSE Midcap
  • CNX 500
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi